Weston, MA, United States of America

Yi Li

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Li. Retrieved from https://idiyas.com/inventor/yi-li-1tgxqrrk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

Average Co-Inventor Count = 28.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi Li: Innovator in Macrocyclic Compounds

Introduction

Yi Li is a prominent inventor based in Weston, MA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of macrocyclic compounds. With a total of 2 patents, his work has the potential to impact various therapeutic areas.

Latest Patents

Yi Li's latest patents focus on macrocyclic compounds, compositions, and methods of using them. The present disclosure includes, among other things, CFTR modulators, pharmaceutical compositions, and methods of making and using the same. These innovations are crucial for advancing treatment options in related medical fields.

Career Highlights

Throughout his career, Yi Li has worked with notable companies such as Genzyme Corporation and Sionna Therapeutics Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Yi Li has collaborated with various professionals in his field, including his coworker George Topalov. These partnerships have fostered an environment of innovation and creativity, leading to the development of impactful solutions in pharmaceutical sciences.

Conclusion

In summary, Yi Li is a dedicated inventor whose work in macrocyclic compounds and CFTR modulators showcases his commitment to advancing pharmaceutical research. His contributions are poised to make a lasting impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…